Cash & equivalents decreased 35.6%
Cash & equivalents changed -35.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$7.2M→$4.7M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →BFRI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory decreased 72.8%
Inventory changed -72.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$4.0M→$1.1M4 prior comparisons
Net income increased 88.7%
Net income changed +88.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$5.3M→-$604,0004 prior comparisons
Operating income increased 89.7%
Operating income changed +89.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$5.1M→-$524,0004 prior comparisons
Operating margin moved 5188 bp higher
Operating margin changed +5188 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-56.25%→-4.37%4 prior comparisons
Research & development decreased 48.5%
Research & development changed -48.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$870,000→$448,0004 prior comparisons
Revenue increased 32.9%
Revenue changed +32.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$9.0M→$12.0M4 prior comparisons
Selling, general & administrative decreased 8.5%
Selling, general & administrative changed -8.5% from the comparable as-filed period.
$10.5M→$9.6M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.